She focuses on the care and treatment of adults with Hodgkin and non-Hodgkin lymphoma. She has a special interest in the development of new agents for lymphoma and in understanding the link between the environment and the prognosis and biology of lymphoma. In addition, she is working to improve the survival of patients with relapsed lymphomas through the use of stem-cell transplantation. She is Principal Investigator of a number of innovative trials, many of which incorporate the collection of tumor and blood samples. She works with collaborative laboratories to study the effects of treatment on cancer cells.